Unprecedented collaboration will initially focus on nanotechnology.

Sanford-Burnham Medical Research Institute (Sanford-Burnham) and Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) today announced they have entered into a three-year comprehensive alliance to develop first-in-class therapeutics for the treatment of cardiovascular-metabolic diseases. The collaboration is built on an open-innovation model to bridge the gap between target discovery and pre-clinical drug development.

As research funding from the National Institutes of Health and other federal agencies shrinks, cooperation among the University of Illinois at Chicago (UIC), Northwestern University and the University of Chicago is expanding.

On May 9, the Global Medical Excellence Cluster (GMEC) announced a five-year collaborative agreement with Pfizer Inc. that provides a framework for the research and development of new and innovative medicines for rare diseases.

It is not news that the research workplace has changed considerably over the past decade. As with many businesses, laboratories have come under pressure to generate better results with ever greater efficiency.

By now we all know that the life sciences industry is radically changing

In addition to the products introduced at Pittcon 2014 we’ve already profiled in our Technology News section, there were plenty of other exciting developments to share from the press conferences we attended in Chicago in March.

Johnson & Johnson Innovation is first collaborator.

Teaming together with major universities on the West Coast, BASF Corporation has set up a multidisciplinary research institute with an emphasis on new inorganic materials and their applications, biosciences, and related technologies.

Researchers at the Wayne State University School of Medicine are among more than 250 scientists in 114 labs in more than 20 countries and regions to publish a series of coordinated papers, including landmark papers in Nature and ten other journals, revealing a definitive list of human cell states that has the potential to serve as an essential resource for regenerative medicine.